138 related articles for article (PubMed ID: 27816956)
21. Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction.
Lazzeri C; Valente S; Chiostri M; D'Alfonso MG; Gensini GF
World J Cardiol; 2014 Apr; 6(4):140-7. PubMed ID: 24772254
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the hemoglobin A1c level in non-diabetic patients undergoing percutaneous coronary intervention: a meta-analysis.
Li Y; Li XW; Zhang YH; Zhang LM; Wu QQ; Bai ZR; Si J; Zuo XB; Shi N; Li J; Chu X
Chin Med J (Engl); 2020 Sep; 133(18):2229-2235. PubMed ID: 32826614
[TBL] [Abstract][Full Text] [Related]
23. Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.
Vora AN; Wang TY; Hellkamp AS; Thomas L; Henry TD; Goyal A; Roe MT
Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):513-22. PubMed ID: 27601458
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis.
Liu Y; Yang YM; Zhu J; Tan HQ; Liang Y; Li JD
Cardiovasc Diabetol; 2011 Nov; 10():98. PubMed ID: 22074110
[TBL] [Abstract][Full Text] [Related]
25. Hemoglobin A1c and short-term outcomes in patients with acute myocardial infarction undergoing primary angioplasty: an observational multicenter study.
Tian L; Zhu J; Liu L; Liang Y; Li J; Yang Y
Coron Artery Dis; 2013 Jan; 24(1):16-22. PubMed ID: 23168569
[TBL] [Abstract][Full Text] [Related]
26. Effect of Coronary Collaterals on Prognosis in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction: A Meta-Analysis.
Cui K; Lyu S; Song X; Yuan F; Xu F; Zhang M; Zhang M; Wang W; Zhang D; Tian J
Angiology; 2018 Oct; 69(9):803-811. PubMed ID: 29656656
[TBL] [Abstract][Full Text] [Related]
27. Long-term prognostic value of admission haemoglobin A1c (HbA1c) levels in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Pusuroglu H; Akgul O; Cakmak HA; Erturk M; Surgit O; Celik O; Ozturk D; Uzun F; Akkaya E; Yildirim A
Postepy Kardiol Interwencyjnej; 2014; 10(3):166-74. PubMed ID: 25489302
[TBL] [Abstract][Full Text] [Related]
28. Skeletal muscle mass is associated with glycemic variability in patients with ST-segment elevation myocardial infarction.
Gohbara M; Iwahashi N; Sato R; Akiyama E; Konishi M; Nakahashi H; Kataoka S; Takahashi H; Kirigaya J; Minamimoto Y; Okada K; Matsuzawa Y; Maejima N; Hibi K; Kosuge M; Ebina T; Sugano T; Ishikawa T; Tamura K; Kimura K
Heart Vessels; 2021 Jul; 36(7):945-954. PubMed ID: 33492437
[TBL] [Abstract][Full Text] [Related]
29. Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose.
Kmet M; Rajer B; Pernat A
Wien Klin Wochenschr; 2014 Mar; 126(5-6):156-62. PubMed ID: 24297265
[TBL] [Abstract][Full Text] [Related]
30. Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis.
Alkatiri AH; Qalby N; Mappangara I; Zainal ATF; Cramer MJ; Doevendans PA; Qanitha A
Front Cardiovasc Med; 2024; 11():1303685. PubMed ID: 38529334
[TBL] [Abstract][Full Text] [Related]
31. Glycated hemoglobin vs fasting plasma glucose as a predictor of left ventricular dysfunction after ST-elevation myocardial infarction.
Tsai JP; Tian J; Wang WY; Ng AC
Can J Cardiol; 2015 Jan; 31(1):44-9. PubMed ID: 25547549
[TBL] [Abstract][Full Text] [Related]
32. Contemporary sex differences in mortality among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
Xi Z; Qiu H; Guo T; Wang Y; Li J; Li Y; Zheng J; Gao R
BMJ Open; 2022 Mar; 12(3):e053379. PubMed ID: 35264344
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.
Timmer JR; Hoekstra M; Nijsten MW; van der Horst IC; Ottervanger JP; Slingerland RJ; Dambrink JH; Bilo HJ; Zijlstra F; van 't Hof AW
Circulation; 2011 Aug; 124(6):704-11. PubMed ID: 21768543
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of admission mean platelet volume to platelet count ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Bolat I; Akgul O; Cakmak HA; Pusuroglu H; Somuncu U; Ozbey S; Ornek V; Erturk M; Gul M
Kardiol Pol; 2016; 74(4):346-55. PubMed ID: 26365942
[TBL] [Abstract][Full Text] [Related]
35. Growth differentiation factor-15 is a predictive biomarker in primary ventricular fibrillation: The RUTI-STEMI-PVF study.
Garcia-Garcia C; Rueda F; Lupon J; Oliveras T; Labata C; Ferrer M; Cediel G; De Diego O; Rodriguez-Leor O; Carrillo X; Bayes-Genis A
Eur Heart J Acute Cardiovasc Care; 2020 Nov; 9(4_suppl):S161-S168. PubMed ID: 30175597
[TBL] [Abstract][Full Text] [Related]
36. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
[TBL] [Abstract][Full Text] [Related]
37. Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis.
Tarantini G; D'Amico G; Brener SJ; Tellaroli P; Basile M; Schiavo A; Mojoli M; Fraccaro C; Marchese A; Musumeci G; Stone GW
JACC Cardiovasc Interv; 2016 Sep; 9(17):1765-76. PubMed ID: 27609250
[TBL] [Abstract][Full Text] [Related]
38. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.
García-García C; Subirana I; Sala J; Bruguera J; Sanz G; Valle V; Arós F; Fiol M; Molina L; Serra J; Marrugat J; Elosua R
Am J Cardiol; 2011 Oct; 108(8):1061-7. PubMed ID: 21791326
[TBL] [Abstract][Full Text] [Related]
39. Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction.
Sager HB; Husser O; Steffens S; Laugwitz KL; Schunkert H; Kastrati A; Ndrepepa G; Kessler T
J Transl Med; 2019 May; 17(1):180. PubMed ID: 31142323
[TBL] [Abstract][Full Text] [Related]
40. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
